Background: Accurate differentiation of kidney diseases such as cysts, tumors, stones, and normal tissue from computed tomography (CT) images remains challenging due to overlapping visual characteristics and variability in data distributions. While deep learning approaches have shown promising results, many existing studies rely on image-level data splitting and focus primarily on accuracy, which may lead to overly optimistic performance and limited clinical reliability. Methods: This study proposes KDH-Net (Kidney Disease Hybrid Network), a hybrid deep learning framework for multiclass kidney disease characterization that integrates EfficientNetB0, ResNet50, and MobileNetV2 through feature-level fusion. A two-stage training strategy is adopted to enhance optimization stability. To ensure realistic performance assessment, experiments on the primary dataset are conducted under a patient-level evaluation protocol, eliminating potential data leakage. The framework further incorporates calibration analysis, statistical validation, and explainable artificial intelligence to evaluate prediction reliability and interpretability. Results: On the patient-level dataset, KDH-Net achieves an overall accuracy of 0.93 with a macro-average F1-score of 0.91, demonstrating balanced performance across all classes. Confidence analysis indicates meaningful alignment between prediction confidence and correctness, while Grad-CAM visualizations highlight anatomically relevant regions associated with each class. Conclusions: The results demonstrate that KDH-Net provides a stable, reliable, and interpretable framework for kidney CT characterization. The proposed system is designed to support clinical decision-making by offering trustworthy predictions under realistic evaluation conditions, rather than replacing clinical expertise.
A central question in hybrid quantum–classical learning is whether variational quantum circuits (VQCs) preserve task-relevant information more efficiently than classical nonlinearities of equal output dimension. We study this question for drug–target interaction prediction in Alzheimer’s disease drug-repurposing workflows using a Hybrid Quantum–Classical Graph Neural Network (HQGNN). The model compresses 512-dimensional GNN embeddings into a four-qubit VQC (128\(\times \) compression) before a classical prediction head. On the DAVIS kinase benchmark, HQGNN achieves concordance index (CI) \(=0.527\) and root mean squared error (RMSE) \(=0.850\), outperforming a dimension-matched classical bottleneck baseline (CI \(=0.500\); random ranking). Under the same compression, the quantum layer recovers 51% of the ranking signal lost by compression relative to the full classical model and yields a 5.4% relative CI gain over the classical bottleneck. This effect is obtained with 24 trainable quantum parameters (representational yield \(\Delta \)CI/parameter \(\approx 1.13\times 10^{-3}\)). Under depolarizing noise, RMSE degradation remains below 3.3% at realistic noisy intermediate-scale quantum (NISQ) levels (\(p \le 0.01\)). Because the present benchmark is evaluated on a single transductive split, these results are interpreted as controlled proof-of-concept evidence of representational efficiency rather than definitive deployment-level generalization.